NCT06319573 The Impact of Personalized Prognostic Counseling on IVF Patient's Experience and Treatment Utilization
| NCT ID | NCT06319573 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ginefiv |
| Condition | Infertility |
| Study Type | INTERVENTIONAL |
| Enrollment | 366 participants |
| Start Date | 2024-03-19 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 366 participants in total. It began in 2024-03-19 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be conducted in two phases. In the first phase, research subjects will be assigned to receive standard counseling. In the second phase, research subjects will receive Univfy counseling.
Eligibility Criteria
Inclusion Criteria: * Patients between 18-43 in age and their healthcare providers have determined that IVF treatment using the patients' own eggs is indicated. Exclusion Criteria:specific to this study only (these are not contraindications to using the Univfy® PreIVF Report): * Same sex couples * Patients undergoing DuoStim and/or PGT-M/-SR * Patients considering egg freezing rather than IVF * Patients considering the use of donor eggs or gestational carrier Patients with contraindications to receiving the Univfy® PreIVF Report For Patients Under 40 Using Their Own Eggs. Those contraindications are: * Patients who are perimenopausal or menopausal * Patients who have very poor IVF results in the past, including: * extremely poor oocyte/embryo quality, no embryos to transfer, * no euploid embryos on PGT-A, no blastocysts in extended culture
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06319573 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 43 Years, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06319573 currently recruiting?
Yes, NCT06319573 is actively recruiting participants. Contact the research team at x.lin@ginefiv.com for enrollment information.
Where is the NCT06319573 trial being conducted?
This trial is being conducted at Barcelona, Spain, Madrid, Spain.
Who is sponsoring the NCT06319573 clinical trial?
NCT06319573 is sponsored by Ginefiv. The trial plans to enroll 366 participants.